Endonovo Therapeutics announced Monday the first commercial sales of its “electroceutical” wearable electronic device for pain relief.
The Woodland Hills company, which makes electronic medical devices, said its first commercial product is designed to prevent pain and swelling after minor surgeries by emitting electrical pulses to recovering tissue. Called SofPulse, it was approved by the Food and Drug Administration in 2008, but the company has only just begun commercializing it. Endonovo is currently seeking distribution partners in Europe, it said in a statement.
“As we battle an opioid epidemic we must look for novel ways to prevent people ... from becoming dependent on narcotics,” Endonovo Chief Executive Allen Collier said in a statement. “We believe our (device) can drastically reduce the need for pain medication use and improve the lives of millions of people.”
Endonovo did not return a request for comment from the Business Journal by press time. Endonovo (ENDV) shares were unchanged Monday, closing at 6 cents on the over-the-counter market.